Sort
25,944 grants matching “neurodegeneration”
Preclinical efficacy of an APOE targeted antibody for Alzheimer's disease
$498,709Jinsam You · Epoch Biotech, Llc · R41 · FY2025 · AG
Commercialization of Selective Dyrk1a Inhibitors for Down Syndrome
$498,634Travis Dunckley · Iluminos Therapeutics, Llc · R42 · FY2022 · NS
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION
$498,493Buck Institute For Age Research · R01 · FY2004 · AG
Mechanisms of synaptic dysfunction in Parkinson's and other synuclein-linked diseases
$498,248Jennifer R Morgan · Marine Biological Laboratory · R01 · FY2017 · NS
Training in Alzheimerâs and Age-Related Neurodegenerative Diseases
$498,168Virginia M Lee · University Of Pennsylvania · T32 · FY2021 · AG
Brain Aging &Gene Expression Patterns Using Microarrays
$497,908University Of California Irvine · R01 · FY2004 · AG
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
$497,811Gerald Warren Hart · University Of Georgia · R01 · FY2021 · DK
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
$497,811Gerald Warren Hart · University Of Georgia · R01 · FY2022 · DK
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
$497,811Gerald Warren Hart · University Of Georgia · R01 · FY2023 · DK
Development of Immunological Reagents for the Identification of New World Monkey Biomarkers
$497,701Luis David Giavedoni · Trinity University · R24 · FY2023 · OD
Gene Delivery and Addiction
$497,686Brandon Harvey · National Institute On Drug Abuse · Z01 · FY2008 · DA
Gene Therapy And Neurodegeneration
$497,686Brandon Harvey · National Institute On Drug Abuse · Z01 · FY2008 · DA
Neuroprotective and neuroregenerative effects of Bone morphogenetic proteins
$497,686Yun Wang · National Institute On Drug Abuse · Z01 · FY2008 · DA
Neuroprotective/regenerative effects of small molecules and trophic factors
$497,686Yun Wang · National Institute On Drug Abuse · Z01 · FY2008 · DA
Exosome based therapeutics in Huntington's disease
$497,621Neil Aronin · Univ Of Massachusetts Med Sch Worcester · UH2 · FY2014 · TR
Molecular mechanisms that regulate vesicle formation and transport
$497,564Anjon Audhya · University Of Wisconsin-Madison · R35 · FY2020 · GM
Novel Lysosomal Enzyme Deficient in Batten Disease
$497,524David Edward Sleat · Rutgers Biomedical And Health Sciences · R01 · FY2023 · NS
Novel Lysosomal Enzyme Deficient in Batten Disease
$497,524David Edward Sleat · Rbhs-Robert Wood Johnson Medical School · R01 · FY2022 · NS
Role of PS1 in neurodegeneration
$497,516Oksana Berezovska · Massachusetts General Hospital · R01 · FY2017 · AG
Amyloid, white matter hyperintensities & outcomes of late-life depression
$497,453Meryl A Butters · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · MH
A Phenotype-Optimized Zebrafish Model of Progressive Supranuclear Palsy
$497,436David Schoppik · New York University School Of Medicine · R61 · FY2022 · NS
HTS to identify small molecules to disrupt abnormal huntingtin interactions in HD
$497,360Nancy A Muma · University Of Kansas Lawrence · R01 · FY2018 · NS
BEHAVIORAL CHARACTERIZATION OF ACUTE&CHRONIC AMPHETAMINE
$497,314University Of California San Diego · R01 · FY2005 · DA
Role of PS1 in neurodegeneration
$497,266Oksana Berezovska · Massachusetts General Hospital · R01 · FY2016 · AG
Novel Lysosomal Enzyme Deficient in Batten Disease
$497,259Peter Lobel · Rbhs-Robert Wood Johnson Medical School · R01 · FY2021 · NS